Inside the Chinese lab poised to study world's most dangerous pathogens.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Biosafety, biosecurity, and bioethics.Monash bioethics review · 2024
   Review
2. The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation.BioEssays : news and reviews in molecular, cellular and developmental biology · 2021
   Article
3. SARS-CoV-2: International Investigation Under the WHO or BWC.Frontiers in public health · 2021
   Article
4. Emerging viral threats and the simultaneity of the non-simultaneous: zooming out in times of Corona.Medicine, health care, and philosophy · 2020
   Article
5. Could SARS-CoV-2 or COVID-19 Be a Biological Weapon?Iranian journal of public health · 2020
   Article
6. 2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus.The western journal of emergency medicine · 2020
   Article
7. Current status and future challenges of high-level biosafety laboratories in China.Journal of biosafety and biosecurity · 2019
   Review
8. Biosafety Level 4 Laboratory User Training Program, China.Emerging infectious diseases · 2019
   Article
9. Networking for training Level 3/4 biosafety laboratory staff.Journal of biosafety and biosecurity · 2019
   Article

Corrections and comments

• Commented on by
  Biosafety: National biosafety standards differ.2017
• Comment on
  Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone.2015

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.